Home / Stocks / Shivalik Rasayan Limited
SHIVALIK

Shivalik Rasayan Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹291.65

Change

+0.45 (0.15%)

Open

₹291.0

Prev. Close

₹291.2

Day High

₹305.0

Day Low

₹287.05

Volume Analysis

Traded

70,458

Delivered

28,716

Delivery %

40.76%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (3)

  • •Low return on equity (2.18%)
  • •Promoter holding is falling
  • •Below-average fundamentals quality score (42/100)

Opportunities (1)

  • •Strong 3-year revenue growth (16.3%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹320.04 ₹312.52 ₹302.09 ₹294.57 ₹284.14 ₹276.62 ₹266.19
Fibonacci ₹312.52 ₹305.66 ₹301.43 ₹294.57 ₹287.71 ₹283.48 ₹276.62
Camarilla ₹296.59 ₹294.94 ₹293.3 ₹294.57 ₹290.0 ₹288.36 ₹286.71

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-18.36%

1 Week

-4.53%

1 Month

-6.58%

3 Months

+7.82%

6 Months

+12.87%

1 Year

-28.17%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹261.78

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

3.27%

Net margin 5.5% × asset turnover 0.45x × equity multiplier 1.32x

Company Overview

Sector

Chemicals

Market Cap

₹489 Cr

P/E (TTM)

34.2

ROE

2.18%

Book Value

₹387.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 15 Nov 2026. Not investment advice.

TopFund Analysis

Shivalik Rasayan Limited scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 42/100. The strongest factor is Financial Strength (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (2.18%); promoter holding is falling. Strong 3-year revenue growth (16.3%).

TopFund Score — Fundamentals Quality

42/100 — Weak

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

36

Valuation

41

Cash Flow

0

Corporate Governance

53

Momentum

43

Institutional Ownership

20

Business Quality

41

Risk & Volatility

28

Liquidity

25

From Screener.in

  • +Stock is trading at 0.79 times its book value
  • −Promoter holding has decreased over last quarter: -0.83%
  • −Company has a low return on equity of 2.69% over last 3 years.
  • −Dividend payout has been low at 5.73% of profits over last 3 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Shivalik Rasayan filed USFDA DMF for Avapritinib API; complete assessment completed.

Company received Regulation 29 disclosure from Ginnerup Capital ApS for warrant acquisition.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 67 70 71 75 82 85 69 89 94 82 103 96 101
Expenses + 57 61 62 65 71 72 64 78 82 72 90 85 86
Operating Profit 10 9 9 9 12 13 6 11 12 10 12 11 15
OPM % 14.41% 12.62% 13.04% 12.57% 14.26% 15.61% 8.3% 12.29% 12.83% 12.58% 12.09% 11.6% 14.75%
Other Income + 1 2 1 1 0 2 6 1 0 1 2 1 0
Interest 2 2 3 2 2 2 3 3 2 2 2 2 3
Depreciation 3 3 3 4 5 5 3 5 5 5 4 4 5
Profit before tax 5 6 5 5 5 8 6 4 5 4 8 6 7
Tax % 45.02% 24.78% 9.09% 16.09% 11.6% 11.38% 13.21% 31.88% 21.35% 11.14% 7.12% 20.49% 20.62%
Net Profit + 3 4 5 4 4 7 5 3 4 4 7 5 5
EPS in Rs 1 2 2 2 3 3 3 1 2 2 3 2 2
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 19 22 13 16 23 21 -3 20 14 -4 48 8 7

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 41 110 123 155 171 186 198 215 234 273 312 368 382
Expenses + 38 99 105 131 147 157 159 167 191 232 271 321 333
Operating Profit 3 10 18 24 24 29 38 47 43 41 41 47 49
OPM % 7.0% 9.0% 15.0% 16.0% 14.0% 16.0% 19.0% 22.0% 19.0% 15.0% 13.0% 13.0% 13.0%
Other Income + 0 1 1 3 8 3 1 4 5 4 8 4 4
Interest 0 5 6 4 3 2 2 3 5 9 8 11 10
Depreciation 0 2 2 2 3 4 9 11 12 12 16 19 18
Profit before tax 3 5 11 20 26 27 29 37 32 23 25 21 24
Tax % 33.0% 33.0% 25.0% 25.0% 20.0% 17.0% 15.0% 7.0% 6.0% 22.0% 12.0% 16.0% —
Net Profit + 2 3 8 15 21 22 25 34 30 18 22 18 21
EPS in Rs 2 4 10 14 10 10 13 18 14 8 11 8 9
Dividend Payout % 0.0% 0.0% 4.0% 3.0% 5.0% 2.0% 4.0% 3.0% 3.0% 6.0% 5.0% 6.0% —
Sales growth — 166 12 26 10 9 6 9 9 16 14 18 13

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 8 11 7 45 158 169 172 280 412 500 528 591 613
Borrowings + 0 31 32 22 20 10 29 38 58 76 105 123 107
Other Liabilities + 11 36 52 81 103 142 155 163 101 109 93 97 92
Total Liabilities 23 81 94 152 288 328 363 488 578 692 734 819 821
Fixed Assets + 7 27 27 40 41 52 210 221 218 214 337 335 333
CWIP 0 0 0 0 26 102 0 3 57 117 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets + 16 53 66 111 222 175 153 264 303 362 398 484 488
Total Assets 23 81 94 152 288 328 363 488 578 692 734 819 821
Equity Capital 3 3 3 4 7 7 7 7 7 8 8 8 8

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 4 12 8 -7 -8 6 59 11 -19 -8 -9 -34
Cash from Investing Activity + 0 -18 -4 -24 -24 -102 -65 -23 -71 -74 -21 -21
Cash from Financing Activity + 1 3 -3 52 100 10 2 78 50 89 21 62
Net Cash Flow 4 -3 2 21 69 -86 -4 66 -40 7 -10 6
Free Cash Flow 3 10 5 -22 -37 -85 -6 -14 -82 -76 -32 -51
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 161 131 52 -21 -12 41 171 37 -31 -9 -16 -66

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 47.95% → 46.54%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 50.28% 48.17% 49.0% 47.87% 46.81% 47.72% 47.71% 47.76% 48.62% 48.43% 51.43% 52.72%
Promoters 47.95% 47.95% 47.95% 47.95% 47.95% 47.37% 47.37% 47.37% 47.37% 47.37% 47.37% 46.54%
FII 1.18% 2.99% 2.15% 3.28% 4.33% 4.28% 4.36% 4.38% 3.9% 4.2% 1.2% 0.72%
DII 0.59% 0.88% 0.88% 0.88% 0.88% 0.64% 0.56% 0.48% 0.12% 0.0% 0.02% 0.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Shivalik Rasayan Limited (this stock) 489 34.2 0.79 2.18%
Primo Chemicals Limited 484 43.9 1.2 3.82%
Aarti Surfactants Limited 476 14.8 1.8 5.16%
Asahi Songwon Color Ltd 460 9.65 1.51 7.14%
Best Agrolife Limited 520 10.8 0.6 1.18%
Alufluoride Ltd. 528 16.5 3.66 22.0%
Chemfab Alkalis Limited 445 — 1.19 -2.49%

Which Mutual Funds Hold Shivalik Rasayan Limited?

Frequently Asked Questions about Shivalik Rasayan Limited

Community Sentiment

What are other investors saying about Shivalik Rasayan Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.